Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: cyclophosphamide|DRUG: docetaxel|DRUG: epirubicin hydrochloride|DRUG: fluorouracil
Sponsor: UNICANCER